Home > Insider Trading > Filing (0001209191-14-077594)

Filing Details

Accession Number:: 0001209191-14-077594
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-23 10:39:22
Reporting Period:: 2014-12-22

Filing Date:: 2014-12-23
Accepted Time:: 2014-12-23 10:39:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1521762	Cadista Holdings Inc.	N/A	Pharmaceutical Preparations (2834)	311259887

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1526254	S. Hari Bhartia	C/O Cadista Holdings Inc. 207 Kiley Drive Salisbury MD 21801	No	No	Yes	No
1526255	S. Shyam Bhartia	C/O Cadista Holdings Inc. 207 Kiley Drive Salisbury MD 21801	No	No	Yes	No
1526256	Jubilant Pharma Holdings Inc.	C/O Jubilant Life Sciences (Usa) Inc. One Crossroads Dr Bedminster NJ 07921	No	No	Yes	No
1526258	Ltd Pharma Jubilant	42B Horne Road Singapore U0 209066	No	No	Yes	No
1526259	Ltd. Sciences Life Jubilant	1-A Sector 16A Institutional Area Noida, Up K7 201-301	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-12-22	20,753,606	$1.60	117,797,190	No	4	P	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnotes

Footnotes

The Reporting Persons and Jubilant Generics Inc., f/k/a Generic Pharmaceuticals Holdings Inc. ("JGI"), previously reported the ownership of 97,043,574 shares of common stock of Cadista Holdings Inc. ("Cadista") pursuant Form 3s filed with the Securities and Exchange Commission (the "SEC").
17,018,378 additional shares were acquired pursuant to a tender offer, commenced on November 13, 2014 (the "Tender Offer") for all issued and outstanding shares of Cadista not already owned by JGI and its affiliates, upon and subject to the conditions set forth in the Offer to Purchase, dated November 13, 2014, as amended and supplemented (as amended and supplemented, the "Offer to Purchase"), which was annexed to and filed with the Tender Offer Statement and Rule 13E-3 Transaction Statement originally filed under cover of Schedule TO by certain of the Reporting Persons with the SEC on November 13, 2014.
The Tender Offer expired at 5:00 p.m. on December 19, 2014, and on December 22, 2014, as contemplated by the Offer to Purchase, JGI effectuated a short-form merger (the "Merger"), pursuant to which JGI was merged with and into Cadista, and Cadista became a wholly-owned subsidiary of Jubilant Pharma Holdings Inc. ("JPH"), which had owned all of the shares of capital stock of JGI at the effective time of the Merger. The shares reported as owned by the Reporting Persons reflects the share ownership of Cadista after the effectiveness of the Merger. All reported securities are owned directly by JPH. JPH is owned by Jubilant Pharma Ltd. ("JPL"). JPL is a wholly-owned subsidiary of Jubilant Life Sciences Ltd. ("JLS").
Shyam S. Bhartia and Hari S. Bhartia, who are brothers, own or control a significant percentage of the equity shares of JLS, and accordingly may be deemed to indirectly own the reported shares. Messrs. Shyam S. Bhartia and Hari S. Bhartia disclaim any beneficial ownership of any shares owned indirectly by JLS, except to the extent of their respective pecuniary interests therein.